NEXGEL (NASDAQ:NXGL) announced that it is developing a brand new eye patch made of hydrogel to treat amblyopia. It is a condition that causes low vision that usually occurs in one eye, but may be seen in both eyes. This condition is also known as lazy eye. The company, based in Pennsylvania, is called Langhorne. stated that the patch will be available for ophthalmologists and optometrists within the first quarter of 2023. World’s Leading Window Coverings Norman USA to appear on Designing Spaces Amblyopia affects the range of 2% to four percent from people in the American population. As per…